Seres Therapeutics Inc (NASDAQ: MCRB) kicked off on Tuesday, down -1.09% from the previous trading day, before settling in for the closing price of $0.89. Over the past 52 weeks, MCRB has traded in a range of $0.54-$2.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 386.36% over the last five years. While this was happening, its average annual earnings per share was recorded 86.61%. With a float of $124.81 million, this company’s outstanding shares have now reached $170.20 million.
The firm has a total of 233 workers. Let’s measure their productivity. In terms of profitability, gross margin is -10887.5%, operating margin of -221404.69%, and the pretax margin is -39804.69%.
Seres Therapeutics Inc (MCRB) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Seres Therapeutics Inc is 26.90%, while institutional ownership is 23.58%. The most recent insider transaction that took place on Nov 18 ’24, was worth 475. In this transaction Chief Legal Officer and EVP of this company sold 878 shares at a rate of $0.54, taking the stock ownership to the 135,192 shares. Before that another transaction happened on Nov 18 ’24, when Company’s insider sold 977 for $0.54, making the entire transaction worth $528. This insider now owns 32,415 shares in total.
Seres Therapeutics Inc (MCRB) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 86.61% per share during the next fiscal year.
Seres Therapeutics Inc (NASDAQ: MCRB) Trading Performance Indicators
Take a look at Seres Therapeutics Inc’s (MCRB) current performance indicators. Last quarter, stock had a quick ratio of 1.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2505.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.19, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.33 in one year’s time.
Technical Analysis of Seres Therapeutics Inc (MCRB)
Analysing the last 5-days average volume posted by the [Seres Therapeutics Inc, MCRB], we can find that recorded value of 1.5 million was lower than the volume posted last year of 4.26 million. As of the previous 9 days, the stock’s Stochastic %D was 57.27%. Additionally, its Average True Range was 0.09.
During the past 100 days, Seres Therapeutics Inc’s (MCRB) raw stochastic average was set at 36.55%, which indicates a significant decrease from 43.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.42% in the past 14 days, which was lower than the 105.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7905, while its 200-day Moving Average is $0.8819. Now, the first resistance to watch is $0.9101. This is followed by the second major resistance level at $0.9400. The third major resistance level sits at $0.9700. If the price goes on to break the first support level at $0.8502, it is likely to go to the next support level at $0.8202. Should the price break the second support level, the third support level stands at $0.7903.
Seres Therapeutics Inc (NASDAQ: MCRB) Key Stats
The company with the Market Capitalisation of 150.30 million has total of 170,738K Shares Outstanding. Its annual sales at the moment are 126,330 K in contrast with the sum of -113,720 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was 88,780 K.
